Agenovir Corporation
http://www.agenovir.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Agenovir Corporation
CRISPR Therapeutics, Vertex Initiate First Industry-Sponsored Trial – What’s Next?
CRISPR Therapeutics and Vertex initiated the first human study of CRISPR gene-editing technology with an industry sponsor, following an investigator-sponsored study initiated in China two years ago. These are not the first gene-editing trials, but they're important milestones for the CRISPR field.
Agenovir: Using Gene Editing To Kill Viral DNA
Emerging Company Profile: Agenovir has a unique gene-editing niche – using CRISPR/Cas9 to destroy DNA in latent viral reservoirs as opposed to other companies that snip and repair errors in the genome.
Execs On The Move, March 2017
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Appointments: Sanofi, Regeneron, Galena, Genmab, Abpro and Myokardia
This week's roundup sees Sanofi appoint Biogen's former SVP of corporate affairs to executive vice president, external affairs. Meanwhile, Galena Biopharma, Abpro, Genmab and Purdue Pharma have all named new executives.
Company Information
- Industry
-
Biotechnology
- Gene Therapy, Cell Therapy
-
Drug Discovery Tools
- Genomics-Proteomics
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice